期刊文献+

环境化合物与帕金森病的研究进展 被引量:2

Advance research on association between environmental compound and parkinson's disease
原文传递
导出
摘要 帕金森病(PD)是仅次于老年痴呆症的第二大最常见的神经退行性疾病。近年来,其发病率有逐年上升的趋势。PD的病因尚不清楚,可能与年龄老化、遗传和环境等综合因素有关,其中环境化合物的影响近来备受关注。来自流行病学、动物实验和细胞培养的研究表明,许多环境化合物参与了线粒体功能障碍、氧化应激、小胶质细胞活化、α-突触核蛋白(α-Syn)异常聚集以及自噬受损等发病机制,从而增加了PD的发生风险。 Parkinson's disease (PD) was the second most common neurodegenerative disorder after Alzheimer's disease. Incidence of PD was ascending year by year. The etiology of PD is poorly understood, involving aging, genetic and environmental factors. Recently, environmental compound had attracted more and more research interest. Studies and extrapolation from epidemiology, animal experiments and cell culture suggested that environmental compound had involved in the molecular mechanisms including mitochondrial dysfunction, oxidative stress, microglia activation,abnormal aggregation of α-synuclein and autophagy damage,which seemed to increase PD risk.
机构地区 上海
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2016年第10期922-926,共5页 Chinese Journal of Preventive Medicine
基金 国家自然科学基金(81373866)
关键词 帕金森病 危险因素 环境化合物 Parkinson disease Risk factors Environmental compound
  • 相关文献

参考文献1

二级参考文献10

  • 1Bartus RT, Weinberg MS, Samulski RJ (2014) Parkinson's disease gene therapy: success by design meets failure by efficacy. Mol Ther 22:487- 497.
  • 2Colla E, Coune P, Liu Y, Pletnikova O, Troncoso JC, Iwatsubo T, Schnei- der BL, Lee MK (2012) Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J Neurosci 32:3306-3320.
  • 3Coune PG, Schneider BL, Aebischer P (2012) Parkinson's disease: gene therapies. Cold Spring Harb Perspect Med 2:a009431.
  • 4Coune PG, Bensadoun JC, Aebischer P, Schneider BL (2011) RablA over-expression prevents Golgi apparatus fragmentation and partial- ly corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease, l Parkinsons Dis 1:373-387.
  • 5Gorbatyuk MS, Shabashvili A, Chert W, Meyers C, Sullivan LF, Salganik M, Lin JH, Lewin AS, Muzyczka N, Gorbatyuk OS (2012) Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther 20:1327-1337.
  • 6Hetz C, Mollereau B (2014) Disturbance of endoplasmic reticulum pro- teostasis in neurodegenerative diseases. Nat Rev Neurosci 15:233-249.
  • 7Hetz C, Chevet E, Harding HP (2013) Targeting the unfolded protein response in disease. Nat Rev Drug Discov 12:703-719.
  • 8Mercado G, Valdes P, Hetz C (2013) An ERcentric view of Parkinson's disease. Trends Mol Med 19:165-175.
  • 9Sado M, Yamasaki Y, Iwanaga T, Onaka Y, Ibuki T, Nishihara S, Mizugu- chi H, Momota H, Kishibuchi R, Hashimoto T, Wada D, Kitagawa H, Watanabe TK (2009) Protective effect against Parkinson's disease-re- lated insults through the activation of XBP 1. Brain Res 1257:16-24.
  • 10Valdes P, Mercado G, Vidal RL, Molina C, Parsons G, Court FA, Mar- tinez A, Galleguillos D, Armentano D, Schneider BL, Hetz C (2014) Control of doparninergic neuron survival by the unfolded pro- tein response transcription factor XBP1. Proc Natl Acad Sci U S A 111:6804-6809.

共引文献1

同被引文献20

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部